ECTTA, The European Cardio Thoracic Transplant Section of ESOT, would like to announce a call for two new Board members. The new ECTTA Board Members will hold office for four years (2023-2027), starting at the ESOT Congress, September 2023. All ESOT/ECTTA affiliates are eligible to submit their applications for the positions. You may nominate yourself
NEW WEBINAR: Chronic Lung Allograft Dysfunction (CLAD) after lung transplantation
We are delighted to announce that registration is now open for our new ECTTA Webinar, taking place on Thursday 2 February 2023 at 18:00 CET! This webinar will provide an up-to-date overview of Chronic Lung Allograft Dysfunction (CLAD), the most common post-transplant problem in lung transplant patients. CLAD is a burning matter in lung transplantation,
ESOT manual for clinical practice guidelines
This handbook formalises the processes associated with the preparation of ESOT CPGs, including selecting topics for new guidelines, writing and reviewing approval, dissemination, and updating. Moreover, it defines the governance of the process.
ECTTA Call for Nominations
We would like to announce a call for nominations for five new Board members. All ESOT/ ECTTA affiliates are welcome to send applications for these positions. The new ECTTA Board Members will hold office for 4 years (2021-2025). ECTTA is the scientific forum to experience exchange on treatment of patients with end-stage heart and lung
ESOT multi-organ registry
On March 5th 2021, ESOT opened a tender for a technical provider that will build the multi-organ registry. ESOT is seeking the support of additional European national authorities and expect to finalise agreement with participating countries by the end of April 2021. In addition, ESOT is establishing contacts with non-European countries and registries. read more
ESOT Congress 2021: Abstract Submission Deadline EXTENDED
The abstract submission deadline for #ESOTcongress has been EXTENDED until Thursday 25th February at 23:59 CET.
The COVID-19 Vaccine Studies
Transplant patients are exceptionally vulnerable to all infections, especially COVID-19, due to immunosuppression and other co-morbidities. There is a clear need for these patients to receive the best available protection against COVID-19 and we strongly believe that they should be considered as a priority group for vaccination across Europe. Furthermore, our patients and the broader
Transplant International is looking for its publishing partner
ESOT is seeking a publisher for its flagship scientific journal, Transplant International, to discuss the transition to an open access journal.
Scientific Highlights – Transplantation Learning Journey TLJ 2.0
We are pleased to announce that our TLJ 2.0 report has been published and is available to read now. Providing a comprehensive summary of TLJ 2.0, this report covers all the highlights from the event, including the key discussion points and outcomes from some of the World’s leading transplant experts. Read the TLJ20Report for the
EKHA Open Letter to EU Policymakers
EKHA Open Letter to EU Policymakers On Behalf Of The European Organ Donation and Transplantation Community “Life After Covid-19: Time to realise a Second EU Action Plan on Organ Donation and Transplantation” EKHA Open Letter on Organ Donation & Transplantation